Sofia Martins

Sofia Martins

Auto-generated profile, based on publicly available information

Sofia Martins

Internal Medicine, Unidade Local de Saúde da Região de Aveiro, Aveiro, Portugal

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
MTMónica Teixeira
Mónica Teixeira
SMSara Macedo
Sara Macedo
TBTânia Batista
Tânia Batista
SMSofia Martins
Sofia Martins
ACAndreia Correia
Andreia Correia
LMLuís Costa Matos
Luís Costa Matos
SUMMARY Drug-induced liver injury (DILI) to flucloxacillin is rare and is classified as idiosyncratic, as it is dependent on individual susceptibility, unpredictable, and dose-independent. The authors present the case of a 74 - year - old man with a history of monoclonal gammopathy under investigation and alcoholic habits of 24 g/day, with asthenia, anorexia, nausea, abdominal discomfort, and fever with three days of evolution. He was treated with two courses of antibiotic therapy with flucloxacillin to erysipelas previously (3 months and 2 weeks before admission). Lab tests showed serum AST levels of 349 U/L, ALT 646 U/L, alkaline phosphatase 302 U/L, GGT 652 U/L, total bilirubin 3.3 mg/dL and direct bilirubin 2.72 mg/dL. Infectious, autoimmune, and metabolic causes were ruled out. Magnetic resonance cholangiopancreatography showed normal results. Liver biopsy showed mild multifocal (predominantly microvesicular) steatosis; marked changes in the centrilobular areas (sinusoidal dilatation, marked congestion, hemorrhage, and multifocal hepatocyte collapse); expansion of the portal areas with the formation of bridges; proliferated bile ducts and inflammatory infiltrate of variable density, predominantly mononuclear type. The HLA-B*5701 screening test was positive. Hepatic biochemical tests remain abnormal with a significative increase in total bilirubin, which reached levels of 24.1 mg/dL, with the development of jaundice, pruritus, and choluria. DILI was assumed, and the patient was treated with ursodeoxycholic acid. There was favorable evolution, without evidence of blood coagulation dysfunction or encephalopathy. The analytic normalization was, however, slow, with evolution to chronicity. The authors present this case to remind the possibility of moderate/severe drug-induced liver injury to flucloxacillin, an antibiotic commonly used in clinical practice and association with the HLA-B * 5701 allele reported in the literature.

1 December 2019 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
SMSofia Costa Martins
Sofia Costa Martins
GVGabriela Venade
Gabriela Venade
MTMónica Teixeira
Mónica Teixeira
JOJoão Olivério
João Olivério
JMJoão Machado
João Machado
LMLuís Costa Matos
Luís Costa Matos
SUMMARY Autoimmune polyglandular syndrome type 2 (APS 2) is defined by the presence of Addison’s disease (AD) associated with autoimmune thyroid disease and/or Type 1 diabetes mellitus (T1DM). It is a rare disease, affecting about 1.4-2 cases/100,000 inhabitants. Its less frequent clinical presentation is the combination of AD, Graves‘ disease, and T1DM. We present the case of a 42-year-old woman with a history of total thyroidectomy due to Graves’ disease, type 2 diabetes mellitus, and hypertension, who sought the ED due to asthenia, dizziness, nausea, and vomiting. She reported having stopped antihypertensive therapy due to hypotension and presented a glycemic record with frequent hypoglycemia. On physical examination, she had cutaneous hyperpigmentation. She had no leukocytosis, anemia, hypoglycemia, hyponatremia or hyperkalemia, and a negative PCR. Serum cortisol <0.5 ug/dl (4,3-22,4), urine free cortisol 9 ug/24h (28-214), ACTH 1384 pg/mL (4,7-48,8), aldosterone and renin in erect position of 0 pg/ml (41-323) and 430.7 uUI/ml (4.4-46.1) respectively. Quantiferon TB was negative; computerized axial tomography of the adrenals showed no infiltrations, hemorrhage, or masses. The 21-hydroxylase antibody assay was positive. B12 vitamin was normal, anti-GAD antibodies were positive, anti-insulin, anti-IA2, and anti-transglutaminase antibodies were all negative. The patient started insulin therapy and treatment for AD with prednisolone and fludrocortisone with good clinical response. This case aims to alert to the need for high clinical suspicion in the diagnosis of AD. Since this is a rare autoimmune disease, it is important to screen for other autoimmune diseases in order to exclude APS.

23 June 2026 in BMJ Case Reports
Verified
Journal Article
Closed access
JFJoão Ricardo Cordeiro Rei De Campos Faia
João Ricardo Cordeiro Rei De Campos Faia
ASAna Paiva Santos
Ana Paiva Santos
SMSofia Martins
Sofia Martins
GCGuilherme Violante Cunha
Guilherme Violante Cunha
Chronic mesenteric ischaemia (CMI) is a rare but potentially life-threatening condition, often underdiagnosed due to its vague and non-specific symptoms. We describe a patient who presented with progressive unintentional weight loss, anorexia and postprandial abdominal pain. Despite extensive investigations, no clear diagnosis was established until CT angiography revealed severe calcified stenosis of the coeliac trunk and superior mesenteric artery. The stenoses of two mesenteric vessels limited perfusion during periods of high metabolic demand, causing postprandial tissue ischaemia, which manifested as abdominal pain, reduced oral intake and consequent weight loss. A multidisciplinary approach led to the diagnosis of CMI and surgical revascularisation via iliomesenteric bypass was performed, resulting in complete resolution of symptoms and weight recovery. This case highlights the importance of considering CMI in older patients with unexplained weight loss and cardiovascular risk factors. Early recognition and timely intervention are crucial to prevent irreversible complications and ensure favourable outcomes.